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Treatment of human neutrophils with pertussis toxin (PT) abolishes chemotaxis in response to either plate- 
let-activating factor (PAF) or f-Met-Leu-Phe (FMLP), and capping induced via the concanavalin A (Con 
A) receptor. These functional effects are accompanied by the inhibition of calcium mobilization by PAF, 
FMLP and Con A. The agent phorbol 12-myristate-13-acetate (PMA) also inhibits chemotaxis and capping 
as well as calcium mobilization by these receptors. In sharp contrast, neither PT, cholera toxin (CT), nor 
PMA, inhibits the phagocytosis of non-opsonized and opsonized Candida albicans, sheep erythrocytes or 
fluorescent latex beads. Our results suggest hat receptor-initiated chemotaxis and capping involve a step 
that is sensitive to PT and PMA, and that phagocytosis is not regulated in a similar fashion. 
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1. INTRODUCTION 
It is now evident from the work carried out in 
several laboratories [l-9] that a pertussis toxin 
(PT) substrate in the human neutrophil regulates 
multiple receptors and functions. Overall, the pro- 
cess probably involves a mechanism of 
phosphoinositide hydrolysis, the generation of 
inositol triphosphate (IPs), and calcium mobiliza- 
tion [l- 131. The importance of the PT substrate in 
the regulation of multiple receptors raises the ques- 
tion of which functions are coordinated by this 
substrate and which other functions might be ex- 
cluded from its control. This question is particular- 
ly important as several hypotheses have been pro- 
posed which connect chemotaxis, capping and en- 
docytosis [ 14-161, although the molecular basis 
for the linkage of selective cell functions has re- 
mained unknown. Here, we have utilized PT to 
probe the range of involvement of its substrate in 
the regulation of chemotaxis, capping and 
phagocytosis. Our results suggest that a PT- 
substrate-associated calcium mobilization step is 
important to the regulation of capping and 
chemotaxis but is less significant in the regulation 
of phagocytosis. 
2. MATERIALS AND METHODS 
2.1. Materials 
Fluorescein isothiocyanate (FITC) latex beads 
were purchased from Polysciences (Warrington, 
PA), and sheep erythrocytes from Colorado Serum 
(Denver, CO). The anti-sheep erythrocyte IgG was 
from Cordis (Miami, FL). Candida albicans was 
taken from Kaiser Hospital reference cultures. The 
purchase of all other materials has been described 
i71. 
2.2. Isolation of neutrophils 
Neutrophils were isolated by sequential cen- 
trifugation on dextran and Ficoll/Hypaque and 
toxin treatment of the cells was as described [7,17]. 
Toxin-treated cells were judged viable by exclusion 
of trypan blue and by phorbol 1Zmyristate 
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13-acetate (PMA) mediated superoxide generation, 
which was unaffected by the toxin. 
2.3. Chemotaxis 
The chemotaxis assay was performed in 
triplicate as follows [18]: 250 111 buffer (control 
well for random migration), or FMLP or PAF 
(1 nM-1 FM) were added to the bottom wells of 
the modified Boyden Chambers. Mi~i~re filters 
(13 mm diameter, 3 pm pore size) were placed on 
top of the wells containing ligands, the upper 
chamber affixed, and 250 /tl of the cell suspension 
(5 x 106) cells per ml in modified Hank’s balanced 
salt solution (HBSS) added to the top wells. The 
chamber was placed in a moist 5% CO2/95% air 
incubator at 37°C for 60 min. The filters were 
removed, stained and the slides counted as in [7]. 
2.4. FITC-Con A capping 
Neutrophils (2 x 10’ cells per mI in modified 
HBSS) were exposed to FITC-Con A (10 pg/ml). 
The reaction was terminated by the addition of 2% 
(w/v) paraformaldehyde. Wet mounts were ex- 
amined for capping as described [7,19]. 
2.5. Measurement of in tra~e~~ular c ieium using 
qzdn2 ~uor~cence 
Fluorescence of quinZloaded cells was 
measured by the method of Tsien et al. [20,21]. 
Neutrophils (lOa cells/ml) were loaded with quin2 
by incubation for 30 min at 37°C with quin2 
acetomethoxy ester in Hepes buffer containing 
150 mM NaCI, 5 mM KCl, 1.3 mM CaClz, 
1.2 mM MgCl2 and 10 mM Hepes, pH 7.4. After 
washing, the ligand was added and the 
fluorescence followed from 100 to 500 s as in 
[7,10,21]. 
2.6. Phago~ytosis 
Systems utilized include uptake of sheep 
erythrocyte-antibody complexes (EA), FITC- 
conjugated C. albicans and FITC-conjugated latex 
beads. 
2.7. Assay for EA uptake by ~~trophi~s 
Opsonimd sheep erythrocytes were prepared as 
described [22-241. Control or toxin-treated 
neutrophils (2 ml, 1 x 10’ cells/ml in modified 
HBSS) were layered on clean glass cover slips (22 
x 22 mm) arranged at the bottom of a 35 mm 
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culture dish and incubated for 30 min at 37°C in a 
humidified 5% Co2/95@/‘0 air incubator to form 
monolayers on the cover slips. The monolayers 
were washed twice with modified HBSS and 
layered with 2 ml EAs (2 x 10’ cells/ml in 
modified HBSS) and further incubated for the in- 
dicated time. The cover slips were removed, 
washed with PBS, dipped for 10 s into distilled 
water to lyse the attached erythrocytes, and fixed 
with 2% p~aformaldehyde for 10 min at room 
temperature. The cover slips were then washed, 
mounted, and examined promptly using a phase- 
contrast Zeiss microscope and an oil immersion 
lens (63 x ). Cells were scored with ingested 
erythrocytes which appeared dark brown. 
2.8. Phagocytosis of C. albicans 
An FITC-labeled preparation of C. albicans was 
prepared as in [25,26]. Control or toxin-treated 
neutrophils (0.9 ml, 1 x 10’ cells/ml) were mixed 
with 0.9 ml micro-orga~sms (1 x 10’ 
organisms/ml) and 0.2 ml heat-treated human 
serum. All reactions were carried out in duplicate 
and a blank with no neutrophils was incorporated 
as well as one with no micro-organisms. The tubes 
were incubated for the times indicated at 37°C 
with continuous slow mixing. At the times in- 
dicated, 0.1 ml aliquots were removed and fixed 
with 2% paraformaldehyde for 10 min at 37°C. 
Wet mounts were prepared and slides examined 
with an epifluorescence Zeiss microscope using an 
oil immersion lens (63 x ). 
2.9. Phagocytosis of polystyrene particles 
Control and toxin-treated neutrophils (1 ml, 1 x 
lo6 cells/ml) were incubated with 1 ml FITC- 
labeled polystyrene latex beads (5 x IO’ 
spheres/~) at 37’C for the times indicated with 
continuous slow mixing [27]. All assays were done 
in duplicate. The cells were then fixed with 2% 
paraformaldehyde for 10 min at 37°C. 
2.10. Calculation of phagocytos~ data 
Data were expressed to determine the percentage 
of cells ingesting particles and the average number 
of particles ingested per cell. The phagocytic index 
is the number of particles ingested per 100 
neutrophils. Both measures are utilized in the 
described experiments. 
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3. RESULTS 
Human neutrophils were pretreated with buffer 
or PT and the concentration dependence of PAF- 
and FMLP-mediated chemotaxis and Con A- 
induced capping examined (fig.lA). Under similar 
conditions, both chemotaxis and the ability of the 
A 
600 
Fig.1. Effects of PT and PMA on chemotaxis and 
capping. Neutrophils were preincubated with PT or 
PMA, with a corresponding buffer incubation for 
control cells, and subsequently examined for chemotaxis 
and capping. The ligands tested in the chemotactic assay 
were FMLP and PAF, while capping was examined with 
FITC-Con A. The percentage of migrating cells was 
defined as those cells (percentage of total) moving a 
distance of 20rm or greater in the Boyden chamber 
assay. The percentage of capped cells is defined as that 
fraction of total cells which had clear protuberance 
development with attendant shape change. Experiments 
were carried out to examine chemotactic and capping 
responses at different concentrations of the ligand in 
control (closed symbols) and PT-treated cells (open 
symbols, lSpg/ml for 90 min at 37°C) (A); and in 
PMA-pretreated cells (5 min at 37°C) (B). Details of the 
chemotaxis and capping assays and treatment conditions 
for PT and PMA pretreatments are described in section 
2. 
lectin receptor to form caps was reduced in PT- 
treated cells. Similar experiments were carried out 
with cells exposed to differing concentrations of 
PMA (fig.lB). A dose-dependent inhibition of 
both responses was noted in PMA-treated cells. 
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Fig.2. Effects of PT and PMA on phagocytosis. Control, CT-, PT- and PMA-pretreated neutrophils were incubated 
with either FITC-conjugated latex beads, opsonized FITC-conjugated C. albicuns, or opsonized antibody-coated 
erythrocytes. The phagocytic index of CT- (closed symbols), or PT-treated (open symbols) cells (A), or the percent 
cellular uptake (B) was monitored as described in section 2. 
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Fig.3. Effect of PT and PMA on calcium mobilization. Human neutrophils, loaded with the fluorescent calcium 
chelator quin2, were pretreated with buffer (closed symbols), PT (open symbols) (A), or PMA (B), under the conditions 
described in section 2. The change in fluorescence intensity in response to the different ligands was monitored 
continuously and the value at the 200 s (FMLP or PAF) or 400 s (Con A) mark is presented inthe above figures. The 
details of the quin2 measurements are given in section 2. The concentration of intracellular calcium corresponding to
the 100% mark was 250 nM (FMLP), 225 nM (PAF) and 280 nM (Con A). 
Phagocytosis was then studied with FITC- 
conjugated latex beads and C. albicans as well as 
opsonized (antibody-coated) sheep erythrocytes 
(fig.2). In sharp contrast to the results obtained 
with chemotaxis and capping, neither PT or CT 
(panel A), nor PMA (panel B) produced inhibition 
of phagocytosis at those concentrations which 
completely suppress the former responses. 
Mobilization of calcium via the receptors for 
PAF, FMLP and Con A was then examined using 
quh&associated fluorescence (fig.3). Inhibition of 
calcium mobilization was noted for all 3 receptors 
in response to treatment with PT (panel A) as well 
as with PMA (panel B). 
4. DISCUSSION 
Our results indicate that a PT substrate is in- 
volved in the regulation of chemotaxis and cap- 
ping. Since pertussis toxin also inhibits calcium 
mobilization from the receptors which initiate 
these processes, a PT substrate related calcium 
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mobilization step would seem to be shared by these 
two processes. 
The inhibition by PMA provides further 
evidence in favor of this hypothesis. The results of 
Sha’afi et al. [ 10,281 have shown that PMA is a po- 
tent inhibitor of calcium mobilization from the 
FMLP receptor. A simple prediction from this 
result would be that other receptors which mobilize 
calcium may also be similarly affected. Our results 
clearly suggest hat this is a general phenomenon 
which applies to the PAF and Con A receptors. An 
important correlate of this observation should be 
that functional responses associated with these 
receptors should be inhibited. This is observed for 
PAF-mediated chemotaxis and Con A-induced 
capping. The possibility that kinase C may modify 
the CT- and PT-sensitive GTP-binding receptor 
regulatory proteins (NJNi components, respec- 
tively) [29] is certainly consistent with our results. 
Phagocytosis is unaffected in neutrophils in 
which the capping and chemotactic responses are 
inhibited by PT and PMA pretreatment. This is 
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observed regardless of the type (latex beads, Can- 
dida, erythrocytes) and state (opsonized or non- 
opsonized) of the particles presented to the cells. 
This result is irn~~~t as it suggests that this pro- 
cess is not under the control of the PT (or CT) 
substrate and thus offers a clear limit to the in- 
volvement of this substrate on cellular functions. 
Recent studies have indicated that cell 
spreading, as well as phagoeytosis, involves low 
levels of calcium mobili~tion although a 
phagocytic mechanism independent of calcium 
mobilization has also been observed [30]. Our 
results suggest hat either the pathway which is in- 
dependent of calcium mobilization may be 
predominant, or calcium mobi~zation induced in 
response to surface or particle contact may not be 
under the control of the PT substrate. Measure- 
ment of calcium mobilization by monitoring the 
changes in fluorescent dyes in single cells [30] will 
be required to test which of these hypotheses may 
be applicable. 
The result presented here allows for an evalua- 
tion of hypotheses offered in the literature [14-161 
that certain processes involving the plasma mem- 
brane may be linked to each other through shared 
structural elements either in the plasma membrane 
or in the cytoskeleton. The nature of such a linkage 
has, however, remained obscure. Our results imply 
that chemotaxis and capping act through a PT 
substrate, possibly involving the control of 
cytoskeletal organization. Consistent with this 
possibility we find that shape change is under the 
control of the PT substrate [7]. Addition~ly, actin 
polymerization in response to cell surface receptors 
is also suppressed by the toxin [7,8]. Thus, a step 
from the PT substrate to actin polymerization, 
probably through a mechanism in which mobilized 
calcium plays an important role, may serve to in- 
tegrate chemotaxis and capping. That phagocyto- 
sis is unaffected implies that receptors associated 
with this process (a subset of Fc gamma, mannose 
6-phosphate, or C3b) might not be associated with 
the types of reactions observed with the PT 
substrate-mediated regulator of the lectin, PAF 
and FMLP receptors. 
A more cautious interpretation of the role of 
‘kinase C’ in neutrophil functions is essential. 
Phorbol esters clearly activate kinase C in 
neutrophils and in other cells [31]. However, such 
an activation would seem to inhibit rather than 
potentiate cellular responses such as chemotaxis, 
capping and associated calcium mobilization. 
These results are difficult to reconcile with the cur- 
rently favored mechanism for chemoattractant 
receptors in which calcium mobilization together 
with diacylglycerol produced from hydrolyzed 
phosphoinositides serves to activate a putative 
kinase C and initiate cellular responses. Two 
possibilities should be considered: (i) that distinct 
kinase C enzymes initiate and regulate neutrophil 
functions; or (ii) that calcium mobilization 
mediated by chemotaxis and capping linked recep- 
tors may result in an enzyme activation other than 
that of kinase C, perhaps by acting directly on 
calcium (e.g. calmodulin) sensitive enzymes. 
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